Eur Rev Med Pharmacol Sci 2021; 25 (20): 6171-6173
DOI: 10.26355/eurrev_202110_26985

Acute tubulointerstitial nephritis after COVID-19 m-RNA BNT162b2 vaccine

H. Dheir, S. Sipahi, G.C. Cakar, S. Yaylaci, T. Hacibekiroglu, O. Karabay

Division of Nephrology, Faculty of Medicine, Sakarya University, Sakarya, Turkey. hamaddheir@sakarya.edu.tr

Free PDF Download

To cite this article

H. Dheir, S. Sipahi, G.C. Cakar, S. Yaylaci, T. Hacibekiroglu, O. Karabay
Acute tubulointerstitial nephritis after COVID-19 m-RNA BNT162b2 vaccine

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 20
Pages: 6171-6173
DOI: 10.26355/eurrev_202110_26985

Keywords Related articles:

  1. Side effects of the BNT162b2 vaccine in the personnel of the Military Central Hospital
  2. Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature
  3. miR-192 prevents renal tubulointerstitial fibrosis in diabetic nephropathy by targeting Egr1
  4. Regulatory mechanism of TGF-β1/SGK1 pathway in tubulointerstitial fibrosis of diabetic nephropathy
  5. Acceptance of COVID-19 vaccine among persons experiencing homelessness in the City of Rome, Italy